Paraquat being linked to Parkinson’s, along with further investigations, led to lawsuits filed against the producers of the chemical.
Many cases were consolidated into a multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois in June 2021.
The defendants in the MDL include:
Multidistrict litigation (MDL) is a special federal legal procedure designed to speed the process of handling complex litigations by consolidating cases and addressing all pretrial procedures in one court.
The chosen district court will oversee discovery and pretrial litigation, ultimately ensuring that consistent rulings follow.
After pretrial proceedings are completed, a few cases that are representative of the issue at hand will be selected for bellwether trials.
Bellwether trials are a small consolidation of lawsuits, taken from the larger group of similar cases in an MDL, to be tried first.
The bellwether trial is essentially a practice run to help anticipate the results of the future similar cases.
The bellwether trial date for the paraquat MDL is set for November 15, 2022.
If you have previously been exposed to Paraquat — or similar herbicide Rotenone — and subsequently developed Parkinson’s disease or signs of ongoing developing Parkinson’s – you may qualify to participate in the Paraquat lawsuit.
Contact the offices of TorHoerman Law today for a free, no-obligation Paraquat lawsuit case consultation.
Our experienced chemical exposure law team can help you assess your case and your best plan of action.
You are not alone.
There are resources and support groups available to guide you.
Help, support, and advice are only a click away:
According to a recent coordination order from the district court, there are nearly 400 lawsuits included in the paraquat multidistrict litigation.
Originally, less than 100 cases were involved in the MDL, but as news spread and more farmers and individuals began to link their Parkinson’s Disease diagnosis to paraquat exposure, they soon filed lawsuits that were included in the MDL.
More cases are likely to be added.
Paraquat is a chemical agent most commonly used as an herbicide on a range of more than 100 different crops.
Paraquat has been found to put those exposed to the chemical at a higher risk for Parkinson’s Disease.
In 2011, the National Institutes of Health (NIH) conducted a study – the Farming and Movement Evaluation (FAME) – which found that exposure to the popular herbicide was linked to a 2.5x higher risk of developing Parkinson’s.
According to the American Council on Science and Health, Paraquat’s relative toxicity of glyphosate, another popularly used herbicide known to be toxic, ranges from 33-250.
A lethal dose for an average person is around 2.5 grams, and it is even more toxic when inhaled.
Paraquat’s toxicity has made it a traditionally popular agent for suicide because it can kill a person with a single sip.
Since the Paraquat MDL is in its early stages, having begun in June of 2021, it will take some time for settlements to be reached.
As mentioned previously, bellwether trials are set to begin on November 15, 2022.
Sixteen (16) cases have been selected as bellwether trials, but the trial date is subject to change.
If the trial date is pushed back further, settlements will also be pushed to a later date.